Delivery Order SPE2DR25D2007-SPE2DR26FM33C
Award Date 1/2/26
Potential Completion Date 1/26/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,797.57 to AmerisourceBergen Drug Corp for TAVALISSE 150 mg tablets (60-count units) on December 23, 2025, with completion expected by January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate headquarters location in Conshohocken, Pennsylvania. TAVALISSE is a prescription medication used to treat immune thrombocytopenia, a blood...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count units) under a firm fixed-price contract valued at $19,563.24, with an ultimate completion date of January 14, 2026. This non-competitive delivery order was issued on December 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tavalisse 100 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $18,533.40 and an ultimate completion date of August 12, 2025. The award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. Tavalisse is a pharmaceutical product used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 60 tablets of Tavalisse 100 mg, a pharmaceutical product for immune thrombocytopenia treatment. The contract, which is a child order under a larger indefinite delivery vehicle, requires completion by November 19, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Tavalisse 100 mg tablets (60 count) with a ceiling value of $9,765.67. This is a firm fixed price delivery order with an ultimate completion date of January 13, 2026, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tavalisse 150 mg tablets (60-count) with a contract ceiling value of $18,593.94. This competitively awarded, non-set-aside delivery order utilizes firm fixed price pricing and is scheduled for completion by October 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $19.6K firm fixed-price delivery order on December 15, 2025, for Tavalisse 150 mg tablets (60-count units). The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9M through December 2026. The pharmaceutical distributor will perform from its corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $9,296.97 delivery order to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count packages) on October 16, 2025, with an ultimate completion date of November 6, 2025. This firm fixed price, competitively awarded contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a contract ceiling value of $9,266.70. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....